Related Experiment Video
Updated: Jul 8, 2026

A Flow Cytometry-Based Cell Surface Protein Binding Assay for Assessing Selectivity and Specificity of an Anticancer Aptamer
Published on: September 13, 2022
Cancer cell targeting using multiple aptamers conjugated on nanorods
Yu-Fen Huang1, Huan-Tsung Chang, Weihong Tan
1Center for Research at Bio/nano Interface, Department of Chemistry and Shands Cancer Center, University of Florida, Gainesville, Florida 32611, USA.
Researchers developed a novel nanoplatform using gold-silver nanorods (Au-Ag NRs) to enhance cancer cell recognition. This multivalent aptamer assembly significantly boosts binding affinity and fluorescence signaling for improved cellular imaging and targeting.
Area of Science:
- Nanotechnology
- Biomedical Engineering
- Molecular Biology
Background:
- Effective cancer diagnosis and therapy rely on precise molecular recognition of specific cells.
- Existing molecular probes like aptamers and antibodies may exhibit weak binding affinities, leading to suboptimal signaling and cell targeting.
- Improving the binding strength and signal amplification of molecular probes is crucial for advancing cellular studies.
Purpose of the Study:
- To develop a nanoplatform for multivalent binding of aptamers to enhance cancer cell recognition.
- To increase both the signal and binding strengths of aptamer probes for improved cellular studies.
- To create advanced molecular binders with enhanced properties for cellular imaging and targeting.
Main Methods:
- Assembly of multiple fluorophore-labeled aptamers onto gold-silver nanorods (Au-Ag NRs).
- Utilizing Au-Ag NRs as a nanoplatform to achieve multivalent interactions with cancer cell membrane receptors.
- Employing flow cytometry to quantify fluorescence signal enhancement and binding affinity.
Main Results:
- Up to 80 aptamers were attached to a single Au-Ag NR, yielding significantly stronger fluorescence signals compared to individual probes.
- The multivalent assembly of aptamers on NRs increased binding affinity with cancer cells by at least 26-fold.
- Flow cytometry revealed over a 300-fold enhancement in fluorescence signal for NR-aptamer-labeled cells.
Conclusions:
- The molecular assembly of aptamers on Au-Ag NRs offers a powerful strategy to overcome limitations of weak binding probes.
- This approach significantly improves cellular imaging and targeting, particularly for cells with low-density binding sites.
- Nanomaterial-based platforms provide advanced molecular binders with greatly enhanced properties for cellular studies.
Related Concept Videos
Targeted Cancer Therapies
There are several types of targeted therapies against specific...
Targeted Cancer Therapies
There are several types of targeted therapies against specific...
